Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Germing

Showing results (81-90 of 339) with videos related to

Pageof 34
Sort By:
Blood|May 25, 2004
Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acidAndrea Kuendgen, Corinna Strupp, Manuel Aivado, et al.
Bone Marrow Transplantation|September 5, 2019
Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantationChristina Rautenberg, Jennifer Kaivers, Ulrich Germing, et al.
Wiener Klinische Wochenschrift|December 10, 2009
[Rationale for bone marrow examination in patients with inflammatory rheumatic diseases]Jutta G Richter, Pascal Gossen, Ulrich Germing, et al.
International Journal of Laboratory Hematology|January 29, 2024
Validation of a novel algorithm with a high specificity in ruling out MDSFelicitas Schulz, Kathrin Nachtkamp, Howard S Oster, et al.
Annals of Hematology|July 12, 2013
Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndromeEsther Zipperer, Jochen G Post, Matthias Herkert, et al.
Leukemia Research|April 7, 2007
Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcomeSabine Knipp, Corinna Strupp, Norbert Gattermann, et al.
European Journal of Haematology|June 25, 2009
Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromesJudith Neukirchen, Sabine Blum, Andrea Kuendgen, et al.
Leukemia Research|October 7, 2019
Neut-X can be successfully used as diagnostic and prognostic tool in MDSAmelie Boquoi, Carmen Barthuber, Judith Strapatsas, et al.
Blood Cancer Journal|August 11, 2019
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patientsTobias Silzle, Sabine Blum, Esther Schuler, et al.
Cancer|June 15, 2007
Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypesSabine Knipp, Barbara Hildebrand, Andrea Kündgen, et al.
Pageof 34

Showing results (81-90 of 339) with videos related to

Sort By:
Pageof 34
Blood|May 25, 2004
Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acidAndrea Kuendgen, Corinna Strupp, Manuel Aivado, et al.
Bone Marrow Transplantation|September 5, 2019
Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantationChristina Rautenberg, Jennifer Kaivers, Ulrich Germing, et al.
Wiener Klinische Wochenschrift|December 10, 2009
[Rationale for bone marrow examination in patients with inflammatory rheumatic diseases]Jutta G Richter, Pascal Gossen, Ulrich Germing, et al.
International Journal of Laboratory Hematology|January 29, 2024
Validation of a novel algorithm with a high specificity in ruling out MDSFelicitas Schulz, Kathrin Nachtkamp, Howard S Oster, et al.
Annals of Hematology|July 12, 2013
Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndromeEsther Zipperer, Jochen G Post, Matthias Herkert, et al.
Leukemia Research|April 7, 2007
Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcomeSabine Knipp, Corinna Strupp, Norbert Gattermann, et al.
European Journal of Haematology|June 25, 2009
Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromesJudith Neukirchen, Sabine Blum, Andrea Kuendgen, et al.
Leukemia Research|October 7, 2019
Neut-X can be successfully used as diagnostic and prognostic tool in MDSAmelie Boquoi, Carmen Barthuber, Judith Strapatsas, et al.
Blood Cancer Journal|August 11, 2019
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patientsTobias Silzle, Sabine Blum, Esther Schuler, et al.
Cancer|June 15, 2007
Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypesSabine Knipp, Barbara Hildebrand, Andrea Kündgen, et al.
Pageof 34